For example, fusion of EGF or an Her2 affibody to the mutated PA enhanced the specificity of the engineered anthrax toxin pore for EGFR/Her2 expressing tumor cells by the factor of 100 [20,21,22]. Here, ERBB2 is linked to neoplasm.